Macular pigment imaging in AREDS2 participants: An ancillary study of AREDS2 subjects enrolled at the moran eye center

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 10, 2012, Pages 6178-6186

  Bernstein, Paul S ^a   Ahmed, Faisal ^a   Liu, Aihua ^a   Allman, Susan ^a   Sheng, Xiaoming ^a   Sharifzadeh, Mohsen ^b   Ermakov, Igor ^b   Gellermann, Werner ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; LIPOFUSCIN; LYCOPENE; OMEGA 3 FATTY ACID; VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN; BIOLOGICAL MARKER;

ADULT; AGE RELATED EYE DISEASE STUDY 2; AGED; ARTICLE; AUTOFLUORESCENCE IMAGING; CONTROLLED STUDY; DISEASE COURSE; EYE DISEASE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OPTICAL DENSITY; PIGMENTATION; PRIORITY JOURNAL; RAMAN SPECTROMETRY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SPATIAL ANALYSIS; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFECT; METABOLISM; MIDDLE AGED; RETINA MACULA DEGENERATION; RETINA MACULA LUTEA; SKIN;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAROTENOIDS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; LUTEIN; MACULA LUTEA; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINAL PIGMENTS; SKIN; XANTHOPHYLLS;

EID: 84871673762     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10275     Document Type: Article

References (42)

1. Kokotas H, Grigoriadou M, Petersen MB. Age-related macular degeneration: genetic and clinical findings. Clin Chem Lab Med. 2010;49:601-616.
2. Bernstein PS. Nutritional interventions against age-related macular degeneration. Acta Hortic. 2009;841:103-112.
3. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr. 2003;23:171-201.
4. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol. 1993;111:104-109.
5. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degener-ation. Eye Disease Case-Control Study Group. JAMA. 1994;272: 1413-1420.
6. SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report no. 22. Arch Ophthalmol. 2007;125:1225-1232.
7. Bone RA, Landrum JT, Guerra LH, Ruiz CA. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr. 2003;133: 992-998.
8. Li B, Vachali P, Bernstein PS. Human ocular carotenoid-binding proteins. Photochem Photobiol Sci. 2010;9:1418-1425.
9. Bhosale P, Larson AJ, Frederick JM, Southwick K, Thulin CD, Bernstein PS. Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem. 2004;279:49447-49454.
10. Li B, Vachali P, Frederick JM, Bernstein PS. Identification of StARD3 as a lutein-binding protein in the macula of the primate retina. Biochemistry. 2011;50:2541-2549.
11. During A, Doraiswamy S, Harrison EH. Xanthophylls are preferentially taken up compared with beta-carotene by retinal cells via a SRBI-dependent mechanism. J Lipid Res. 2008;49:1715-1724.
12. Kiefer C, Sumser E, Wernet MF, Von Lintig J. A class B scavenger receptor mediates the cellular uptake of carotenoids in Drosophila. Proc Natl Acad Sci U S A. 2002;99:10581-10586.
13. Tserentsoodol N, Gordiyenko NV, Pascual I, Lee JW, Fliesler SJ, Rodriguez IR. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol Vis. 2006;12:1319-1333.
14. Sakudoh T, Iizuka T, Narukawa J, et al. A CD36-related transmembrane protein is coordinated with an intracellular lipid-binding protein in selective carotenoid transport for cocoon coloration. J Biol Chem. 2010;285:7739-7751.
15. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436.
16. Jampol LM. Antioxidants, zinc, and age-related macular degeneration: results and recommendations. Arch Ophthalmol. 2001;119: 1533-1534.
17. Satia JA, Littman A, Slatore CG, Galanko JA, White E. Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol. 2009;169:815-828.
18. Tanvetyanon T, Bepler G. Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands. Cancer. 2008;113:150-157.
19. Touvier M, Kesse E, Clavel-Chapelon F, Boutron-Ruault MC. Dual association of beta-carotene with risk of tobacco-related cancers in a cohort of French women. J Natl Cancer Inst. 2005;97:1338-1344.
20. Tan JS, Wang JJ, Flood V, Mitchell P. Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch Ophthalmol. 2009;127:656-665.
21. Augood C, Chakravarthy U, Young I, et al. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr. 2008;88:398-406.
22. Chiu CJ, Klein R, Milton RC, Gensler G, Taylor A. Does eating particular diets alter the risk of age-related macular degeneration in users of the Age-Related Eye Disease Study supplements? Br J Ophthalmol. 2009;93:1241-1246.
23. Age-Related-Eye-Disease-Study-2/(AREDS2). Current version January 21, 2009. May be accessed at http://clinicaltrials.gov/ct2/ show/NCT00345176?term=AREDS2&rank=1 (accessed May 27, 2011).
24. Bernstein PS, Delori FC, Richer S, van Kuijk FJ, Wenzel AJ. The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders. Vision Res. 2010;50:716-728.
25. Sharifzadeh M, Bernstein PS, Gellermann W. Nonmydriatic fluorescence-based quantitative imaging of human macular pigment distributions. J Opt Soc Am A Opt Image Sci Vis. 2006;23: 2373-2387.
26. Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA. Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis. 2001;18:1212-1230.
27. Sasamoto Y, Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Nishida K. Effect of cataract in evaluation of macular pigment optical density by autofluorescence spectrometry. Invest Ophthalmol Vis Sci. 2011;52:927-932.
28. Ermakov IV, Ermakova MR, McClane RW, Gellermann W. Resonance Raman detection of carotenoid antioxidants in living human tissues. Opt Lett. 2001;26:1179-1181.
29. Ermakov IV, Sharifzadeh M, Bernstein PS, Gellermann W. Application of resonance Raman spectroscopy to the detection of carotenoids in vivo. In: Landrum JT, ed. Carotenoids: Physical, Chemical, and Biological Functions and Properties. Atlanta, GA: CRC Press; 2009:87-109.
30. Ermakov IV, Gellermann W. Validation model for Raman based skin carotenoid detection. Arch Biochem Biophys. 2010;504:40-49.
31. Mayne ST, Cartmel B, Scarmo S, et al. Noninvasive assessment of dermal carotenoids as a biomarker of fruit and vegetable intake. Am J Clin Nutr. 2010;92:794-800.
32. Britton G. UV/visible spectroscopy. In: Britton G, Liaaen-Jensen S, Pfander H, eds. Carotenoids. Basel, Switzerland: Birkhaeuser; 1995:13-62.
33. Zechmeister L. Cis-trans Isomeric Carotenoids, Vitamins A, and Arylpolyenes. 1st ed. New York: Academic Press; 1962.
34. Bhosale P, Zhao da Y, Serban B, Bernstein PS. Identification of 3-methoxyzeaxanthin as a novel age-related carotenoid metabolite in the human macula. Invest Ophthalmol Vis Sci. 2007;48:1435-1440.
35. Bhosale P, Serban B, Bernstein PS. Retinal carotenoids can attenuate formation of A2E in the retinal pigment epithelium. Arch Biochem Biophys. 2009;483:175-181.
36. Ermakov IV, Sharifzadeh M, Ermakova M, Gellermann W. Resonance Raman detection of carotenoid antioxidants in living human tissue. J Biomed Opt. 2005;10:064028.
37. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res. 1997;65:57-62.
38. Berendschot TT, Plat J, de Jong A, Mensink RP. Long-term plant stanol and sterol ester-enriched functional food consumption, serum lutein/zeaxanthin concentration and macular pigment optical density. Br J Nutr. 2009;101:1607-1610.
39. Zeimer M, Hense HW, Heimes B, Austermann U, Fobker M, Pauleikhoff D. The macular pigment: short-and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study [in German]. Ophthalmologe. 2009;106:29-36.
40. Malinow MR, Feeney-Burns L, Peterson LH, Klein ML, Neuringer M. Diet-related macular anomalies in monkeys. Invest Ophthalmol Vis Sci. 1980;19:857-863.
41. Sandberg MA, Johnson EJ, Berson EL. The relationship of macular pigment optical density to serum lutein in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2010;51:1086-1091.
42. Johnson EJ, Chung HY, Caldarella SM, Snodderly DM. The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation. Am J Clin Nutr. 2008;87: 1521-1529.